The overall goal of the UCLA Alzheimer PPG Program (APP) is to understand in late life depression and age-related memory loss and currently focuses on early detection and prevention of Alzheimer's disease. Emerging therapies for Alzheimer's disease are more likely to slow the disease process rather than to reverse existing brain damage. Thus, identifying persons with only mild mental impairment, who are at risk for developing the disease, will facilitate anti-dementia treatments before extensive brain damage occurs. Using positron emission tomography (PET), a method of imaging biological processes, we have demonstrated a specific brain pattern for Alzheimer's disease that can be identified several years before the clinician is able to confirm the diagnosis.

This program allows authorized investigators to view CT, MRI, PET resliced and PET parametric patient images and analyzed information (blood curve, Ecat data). It also allows dbase administrator to create, update and maintain dbase.
To access our system, your machine needs to be registered with our server and also requires an account. To request an account please send your email to dtruong@mednet.ucla.edu.

To protect confidental patient data, all patient image data and information must be used only by authorized users and the users must follow the Medical Human Subject Protection Committee (HSPC) and UCLA university guidelines. By reading this paragraph you are hereby agreeing to adhere to this restriction.